Bortezomib plus melphalan and prednisone for mu... [N Engl J Med. 2008] - PubMed

Save items

loading

Related citations in PubMed

Bortezomib plus melphalan and prednisone for multiple myeloma. [N Engl J Med. 2008]
Bortezomib plus melphalan and prednisone for multiple myeloma.
Tsubokura M, Kami M, Komatsu T. N Engl J Med. 2008 Dec 11; 359(24):2613; author reply 2613-4.
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial. [J Clin Oncol. 2010]
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial.
Palumbo A, Bringhen S, Rossi D, Cavalli M, Larocca A, Ria R, Offidani M, Patriarca F, Nozzoli C, Guglielmelli T, et al. J Clin Oncol. 2010 Dec 1; 28(34):5101-9. Epub 2010 Oct 12.
Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment. [Blood. 2011]
Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment.
Morabito F, Gentile M, Mazzone C, Rossi D, Di Raimondo F, Bringhen S, Ria R, Offidani M, Patriarca F, Nozzoli C, et al. Blood. 2011 Nov 24; 118(22):5759-66. Epub 2011 Sep 27.
Review [Therapy of multiple myeloma: indications and options]. [Internist (Berl). 2007]
Review [Therapy of multiple myeloma: indications and options].
Peest D, Ganser A. Internist (Berl). 2007 Dec; 48(12):1343-8.
Review Novel therapies in multiple myeloma for newly diagnosed nontransplant candidates. [Cancer J. 2009]
Review Novel therapies in multiple myeloma for newly diagnosed nontransplant candidates.
Kristinsson SY, Landgren O, Rajkumar VS. Cancer J. 2009 Nov-Dec; 15(6):473-8.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Bortezomib plus melphalan and prednisone for multiple myeloma.
Bortezomib plus melphalan and prednisone for multiple myeloma.
N Engl J Med. 2008 Dec 11 ;359(24):2613; author reply 2613-4.

PubMed
The actin-binding domain of cortactin is dynamic and unstructured and affects la...
The actin-binding domain of cortactin is dynamic and unstructured and affects lateral and longitudinal contacts in F-actin.
Cell Motil Cytoskeleton. 2009 Feb ;66(2):90-8.

PubMed
Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma...
Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses.
Int J Cancer. 2009 Apr 1 ;124(7):1721-6.

PubMed
Methionine depletion with recombinant methioninase: in vitro and in vivo efficac...
Methionine depletion with recombinant methioninase: in vitro and in vivo efficacy against neuroblastoma and its synergism with chemotherapeutic drugs.
Int J Cancer. 2009 Apr 1 ;124(7):1700-6.

PubMed
Sleep disorders in dialysis patients.
Sleep disorders in dialysis patients.
Int J Artif Organs. 2008 Nov ;31(11):919-27.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Bortezomib plus melphalan and prednisone for multiple myeloma.

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information